Saturday 17 October 2026
Export TLPH’s income statement to Excel — free account
Talphera, Inc.
TLPH Healthcare Drug Manufacturers Specialty & Generic
In the quarter to June 2026, revenue fell 99.6%, EPS grew 40.0% and free cash flow fell 33.1%, each against the same quarter a year earlier. Operating cash flow growth for five consecutive years; insiders bought in the last twelve months.
1.08
0.01
+0.93%
Follow TLPH
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | — | 0.00 | 0.34 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
— | — | 4 | 3 | 4 | 4 | 1 | 4 | 2 | 1 |
P/S ratio |
113.49 | — | 11.69 | 9.26 | 23.82 | 19.52 | 72.99 | 62.73 | 12.02 | 6.66 |
Altman Z-Score |
(20.73) | — | (31.77) | (13.61) | (9.15) | (10.17) | (6.52) | (3.35) | (5.80) | (2.71) |
Altman Z″-Score (non-manufacturers) |
(49.59) | — | (71.94) | (30.43) | (20.56) | (23.31) | (14.35) | (6.27) | (12.32) | (5.06) |
P/FCF ratio |
0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | — | — | — | — | — | — | — | — | (1.19) |
P/Operating CF |
(19.85) | — | (2.67) | (3.03) | (8.39) | (16.71) | (11.80) | (15.01) | (14.40) | (11.20) |
P/B ratio |
2.84 | — | 0.75 | 0.75 | 0.00 | 0.00 | 0.00 | 31.73 | 0.00 | 0.00 |
Price to Tangible BV |
2.84 | — | 0.75 | 0.75 | 0.00 | 0.00 | 0.00 | 31.73 | 0.00 | 0.00 |
EV/Sales |
80.58 | — | 8.34 | 2.27 | 12.17 | 15.64 | 55.08 | 19.16 | 6.85 | 3.27 |
EV/EBITDA |
0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(3.02) | — | (0.43) | (0.14) | (1.14) | (2.20) | (2.46) | (1.42) | (1.84) | (1.93) |
EV/FCF |
(3.93) | — | (0.51) | (0.13) | (1.08) | (2.10) | (2.31) | (1.38) | (1.70) | (1.71) |
Quick Ratio |
5.35 | 3.35 | 2.08 | 1.51 | 2.53 | 2.47 | 4.89 | 6.66 | 4.54 | 8.45 |
Current Ratio |
5.49 | 3.56 | 2.57 | 1.78 | 2.73 | 2.66 | 5.27 | 6.78 | 4.64 | 8.74 |
Net Debt/EBITDA |
1.50 | 0.58 | 0.57 | 0.65 | 0.97 | 0.54 | 0.78 | 2.67 | 1.12 | 1.96 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 11.29% | 17.72% | 33.00% | 27.53% | 9.95% | 25.28% | 21.55% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.25 | (0.38) | (0.39) | (0.61) | 2.82 | (0.52) | (4.04) |
Asset Turnover |
0.00 | 0.00 | 0.02 | 0.03 | 0.04 | 0.07 | 0.02 | 0.02 | 0.09 | 0.15 |
Operating CF/Net income |
0.80 | 0.98 | 0.95 | (0.67) | 0.85 | 0.95 | 0.96 | 0.62 | 0.58 | 0.68 |
Capex/Depreciation |
0.00 | 0.00 | 9.14 | (1.25) | (0.93) | (1.00) | (2.08) | (1.42) | (1.38) | (1.81) |
Interest Coverage |
— | (38.71) | (126.04) | (22.67) | 48.15 | 8,192.60 | (45.25) | (2.84) | (2.76) | (2.63) |
| (114.16%) | (117.65%) | (102.44%) | (601.31%) | 76.60% | 83.11% | 286.51% | 292.34% | 246.18% | (310.75%) | |
| (59.60%) | (67.32%) | (54.20%) | 67.52% | (48.69%) | (51.23%) | (50.25%) | (48.09%) | (58.68%) | (37.89%) | |
ROIC |
0.00% | 0.00% | (223.45%) | (246.80%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(83.61%) | (192.08%) | (260.43%) | 392.08% | (73.26%) | (90.02%) | (73.30%) | (45.53%) | (84.71%) | (48.18%) |
Average Days of Receivables |
0.00 | — | 0.00 | 0.00 | 20.72 | 42.79 | 68.89 | 68.05 | 69.99 | 122.66 |
Research and Development Expense of Revenue |
21,546.43% | 0.00% | 851.92% | 188.65% | 145.32% | 74.17% | 203.63% | 610.74% | 242.76% | 123.30% |
Selling, General and Administrative Expense of Revenue |
26,710.71% | 0.00% | 1,842.40% | 960.53% | 1,097.76% | 670.79% | 1,967.10% | 965.36% | 207.74% | 89.86% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
2,496.43% | 0.00% | 265.59% | 163.13% | 163.56% | 81.68% | 220.93% | 240.26% | 53.71% | 25.81% |
Graham Net Nets |
0.17 | — | 0.50 | (0.07) | (0.94) | (0.71) | (0.37) | (0.06) | (0.51) | (0.14) |
Graham Number |
0.00 | — | 0.00 | 20.72 | 27.96 | 53.15 | 56.16 | 0.00 | 88.20 | 31.57 |
Earnings Yield |
(32.46%) | — | (200.00%) | 290.99% | (51.79%) | (38.71%) | (31.75%) | (35.50%) | (54.15%) | (36.86%) |
Free Cash Flow Yield |
(18.08%) | — | (140.87%) | (185.32%) | (47.42%) | (38.18%) | (32.71%) | (22.16%) | (33.47%) | (28.66%) |
Revenue per Share |
0.00 | 0.00 | 0.05 | 0.24 | 0.47 | 1.27 | 0.58 | 0.74 | 3.41 | 7.66 |
Operating CF per Share |
(0.27) | (0.49) | (1.23) | (3.84) | (5.01) | (9.03) | (12.93) | (9.96) | (12.70) | (12.97) |
Capex per Share |
0.00 | 0.00 | 0.18 | (0.28) | (0.30) | (0.44) | (0.88) | (0.28) | (1.03) | (1.64) |
Free Cash Flow per Share |
(0.27) | (0.49) | (1.04) | (4.11) | (5.31) | (9.47) | (13.80) | (10.24) | (13.72) | (14.62) |
Cash per Share |
0.48 | 0.34 | 0.66 | 2.81 | 7.78 | 10.06 | 16.70 | 36.20 | 25.80 | 35.45 |
Shareholders Equity per Share |
0.40 | 0.31 | 0.99 | 2.95 | (5.99) | (13.08) | (10.46) | 1.46 | (15.57) | (2.36) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.40 | 0.31 | 0.99 | 2.95 | (5.99) | (13.08) | (10.46) | 1.46 | (15.57) | (2.36) |
Free Cash Flow |
(11.36) | (12.68) | (14.87) | (30.38) | (31.83) | (40.36) | (54.65) | (29.89) | (32.17) | (33.11) |
Working Capital |
17.09 | 6.77 | 7.06 | 10.80 | 31.98 | 29.20 | 58.08 | 92.07 | 49.75 | 78.86 |
Capital Expenditures |
— | — | 2.62 | (2.05) | (1.83) | (1.85) | (3.47) | (0.82) | (2.40) | (3.72) |
Net Current Asset Value |
8.22 | (0.82) | 5.29 | (1.11) | (63.30) | (75.21) | (61.09) | (8.29) | (48.65) | (16.28) |
EV/EBIT |
0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | — | (4.03) | 1.16 | 0.65 | 0.34 | 1.52 | 0.38 | 0.30 | 0.21 |
Price to Operating Income |
0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.12 | 0.12 | 0.11 | 0.05 | 0.16 | 0.19 |
Cash ROIC |
(30.37%) | (75.21%) | (63.31%) | (63.37%) | (129.70%) | (447.90%) | (109.59%) | (24.51%) | (74.72%) | (34.31%) |
Accounts Receivable Turnover |
0.00 | — | 0.00 | 7.55 | 7.09 | 10.15 | 5.50 | 2.22 | 2.17 | 3.81 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 1.55 | 2.71 | 3.59 | 2.28 | 7.15 | 7.90 |
Inventory Turnover |
— | — | — | 0.00 | 2.74 | 2.45 | 3.28 | 4.39 | 6.85 | 9.40 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 206.28 | 165.62 | 92.24 | 190.03 | 48.76 | 46.18 |
Days of Inventory on Hand |
— | — | — | 165.95 | 108.05 | 98.39 | 176.71 | 78.40 | 32.74 | 63.84 |
Average Receivables |
— | — | — | 0.23 | 0.40 | 0.53 | 0.42 | 0.97 | 3.68 | 4.56 |
Average Payables |
0.61 | 1.00 | 1.30 | 1.69 | 2.43 | 2.23 | 1.90 | 1.75 | 1.49 | 1.56 |
Average Inventory |
— | — | — | 1.14 | 1.37 | 2.46 | 2.07 | 0.91 | 1.56 | 1.31 |
Average Assets |
23.98 | 19.32 | 33.94 | 62.69 | 72.09 | 78.83 | 105.94 | 98.04 | 87.77 | 113.89 |
Average Common Equity |
12.52 | 11.05 | 17.96 | (7.04) | (45.82) | (48.58) | (18.58) | (16.13) | (20.92) | 13.89 |
Columns are period end dates